Toxoplasmosis

Evengard, 2001, Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden, Epidemiol Infect, 127, 121, 10.1017/S0950268801005775 Jenum, 1998, Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women, J Clin Microbiol, 36, 2900, 10.1128/JCM.36.10.2900-2906.1998 Forsgren M, Gille E, Ljungstrom I., Toxoplasma antibodies in pregnant women in Sweden in 1969, 1979 and 1987. Lancet 1991; 337:1413–14. Welton, 2005, A model of toxoplasmosis incidence in the UK: evidence synthesis and consistency of evidence, J R Stat Soc Ser C Appl Stat, 54, 385, 10.1111/j.1467-9876.2005.00490.x Jones, 2003, Toxoplasma gondii infection in the United States, 1999-2000, Emerg Infect Dis, 9, 1371, 10.3201/eid0911.030098 McQuillan, 2004, Racial and ethnic differences in the seroprevalence of 6 infectious diseases in the United States: data from NHANES III, 1988-1994, Am J Public Health, 94, 1952, 10.2105/AJPH.94.11.1952 Bahia-Oliveira, 2003, Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil, Emerg Infect Dis, 9, 55, 10.3201/eid0901.020160 Hung, 2005, Prevalence of Toxoplasma gondii infection and incidence of toxoplasma encephalitis in non-haemophiliac HIV-1-infected adults in Taiwan, Int J STD AIDS, 16, 302, 10.1258/0956462053654230 Singh, 2004, Incidence and prevalence of toxoplasmosis in Indian pregnant women: a prospective study, Am J Reprod Immunol, 52, 276, 10.1111/j.1600-0897.2004.00222.x Nissapatorn, 2003, Toxoplasmosis: prevalence and risk factors, J Obstet Gynaecol, 23, 618, 10.1080/01443610310001604376 Elnahas, 2003, Toxoplasmosis in pregnant Sudanese women, Saudi Med J, 24, 868 Millogo, 2000, Toxoplasma serology in HIV infected patients and suspected cerebral toxoplasmosis at the Central Hospital of Bobo-Dioulasso (Burkina Faso), Bull Soc Pathol Exot, 93, 17 Gilbert, 1999, Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications, Epidemiol Infect, 123, 283, 10.1017/S0950268899002800 Dubey, 1996, Strategies to reduce transmission of Toxoplasma gondii to animals and humans, Vet Parasitol, 64, 65, 10.1016/0304-4017(96)00961-2 Dubey, 2000, Sources of Toxoplasma gondii infection in pregnancy. Until rates of congenital toxoplasmosis fall, control measures are essential, Br Med J, 321, 127, 10.1136/bmj.321.7254.127 Hill, 2002, Toxoplasma gondii: transmission, diagnosis and prevention, Clin Microbiol Infect, 8, 634, 10.1046/j.1469-0691.2002.00485.x Kapperud, 1996, Risk factors for Toxoplasma gondii infection in pregnancy. Results of a prospective case-control study in Norway, Am J Epidemiol, 144, 405, 10.1093/oxfordjournals.aje.a008942 Buffolano, 1996, Risk factors for recent toxoplasma infection in pregnant women in Naples, Epidemiol Infect, 116, 347, 10.1017/S0950268800052675 Cook, 2000, Buffolano W et al. Sources of toxoplasma infection in pregnant women: European multicentre case–control study. European Research Network on Congenital Toxoplasmosis, Br Med J, 321, 142, 10.1136/bmj.321.7254.142 Conyn-van Spaedonck, 1991, Choices in preventive strategies: experience with the prevention of congenital toxoplasmosis in The Netherlands, Scand J Infect Dis, 84, 51 Lopez, 2000, Preventing congenital toxoplasmosis, MMWR Recomm Rep, 49, 59 Sibley, 1992, Virulent strains of Toxoplasma gondii comprise a single clonal lineage, Nature, 359, 82, 10.1038/359082a0 Grigg, 2001, Unusual abundance of atypical strains associated with human ocular toxoplasmosis, J Infect Dis, 184, 633, 10.1086/322800 Khan, 2005, Composite genome map and recombination parameters derived from three archetypal lineages of Toxoplasma gondii, Nucleic Acids Res, 33, 2980, 10.1093/nar/gki604 Peyron, 2006, Serotyping of Toxoplasma gondii in pregnant women. Predominance of type II in the old world and type I and III in the new world, Microb Infect, 8, 2333, 10.1016/j.micinf.2006.03.023 Ferreira Ade, 2006, Genetic analysis of natural recombinant Brazilian Toxoplasma gondii strains by multilocus PCR-RFLP, Infect Genet Evol, 6, 22, 10.1016/j.meegid.2004.12.004 Khan, 2006, Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil, Emerg Infect Dis, 12, 942, 10.3201/eid1206.060025 Vallochi, 2005, The genotype of Toxoplasma gondii strains causing ocular toxoplasmosis in humans in Brazil, Am J Ophthalmol, 139, 350, 10.1016/j.ajo.2004.07.040 Ajzenberg, 2002, Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings, J Infect Dis, 186, 684, 10.1086/342663 Howe, 1997, Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis, J Clin Microbiol, 35, 1411, 10.1128/JCM.35.6.1411-1414.1997 Kong, 2003, Serotyping of Toxoplasma gondii infections in humans using synthetic peptides, J Infect Dis, 187, 1484, 10.1086/374647 Liesenfeld, 1997, False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test, J Clin Microbiol, 35, 174, 10.1128/JCM.35.1.174-178.1997 Liesenfeld, 2001, Effect of testing for IgG avidity in the diagnosis of T. gondii infection in pregnant women: experience in a U.S. reference laboratory, J Infect Dis, 183, 1248, 10.1086/319672 Liesenfeld, 2001, Confirmatory serological testing for acute toxoplasmosis and rate of induced abortions among women reported to have positive Toxoplasma immunoglobulin M antibody titers, Am J Obstet Gynecol, 184, 140, 10.1067/mob.2001.108341 Jenum, 1997, Improved diagnosis of primary T. gondii infection in early pregnancy by determination of anti-toxoplasma immunoglobulin G avidity, J Clin Microbiol, 35, 1972, 10.1128/JCM.35.8.1972-1977.1997 Jenum, 1998, Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women, J Clin Microbiol, 36, 2900, 10.1128/JCM.36.10.2900-2906.1998 Robert, 2001, Petersen E and the European Network on Congenital Toxoplasmosis. Potential of the specific markers in the early diagnosis of Toxoplasma-infection: a multicentre study using combination of isotype IgG, IgM, IgA and IgE with values of avidity assay, Eur J Clin Microbiol Infect Dis, 20, 467, 10.1007/s10096-001-8153-1 Lappalainen, 1993, Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG, J Infect Dis, 167, 691, 10.1093/infdis/167.3.691 Hedman, 1989, Recent primary Toxoplasma infection indicated by a low avidity of specific IgG, J Infect Dis, 159, 726, 10.1093/infdis/159.4.736 Petersen, 2005, European multicentre study of the LIAISON automated diagnostic system for determination of specific IgG, IgM and IgG-avidity index in toxoplasmosis, J Clin Microbiol, 43, 1570, 10.1128/JCM.43.4.1570-1574.2005 Montoya, 2002, VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women, J Clin Microbiol, 40, 2504, 10.1128/JCM.40.7.2504-2508.2002 Sensini, 1996, IgG avidity in the serodiagnosis of acute Toxoplasma gondii infection: a multicentre study, Clin Microbiol Infect, 2, 25, 10.1111/j.1469-0691.1996.tb00196.x Beghetto, 2003, Diagnosis of primary T. gondii infection in pregnancy by an IgG avidity assay based on recombinant antigens, J Clin Microbiol, 41, 5414, 10.1128/JCM.41.12.5414-5418.2003 Montoya, 2002, Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis, J Infect Dis, 185, S73, 10.1086/338827 Thalib, 2005, Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluid, Br J Obstet Gynaecol, 112, 567, 10.1111/j.1471-0528.2005.00486.x Switaj, 2005, Recent trends in molecular diagnostics for Toxoplasma gondii infections, Clin Microbiol Infect, 11, 170, 10.1111/j.1469-0691.2004.01073.x Thulliez, 2001, Maternal and foetal infection, 193 Guerina, 1994, Neonatal serologic screening and early treatment for congenital T. gondii infection. The New England Regional Toxoplasma Working Group, N Engl J Med, 330, 1858, 10.1056/NEJM199406303302604 Lebech, 1999, Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment, Lancet, 353, 1834, 10.1016/S0140-6736(98)11281-3 Neto, 2004, Newborn screening for congenital infectious diseases, Emerg Infect Dis, 10, 1069, 10.3201/eid1006.030830 Sørensen, 2002, An automated time-resolved immunofluometric assay for detection of T. gondii-specific IgM and IgA antibodies in filter paper samples from newborns, Clin Chem, 48, 1981, 10.1093/clinchem/48.11.1981 Gras, 2004, Duration of the IgM response in women acquiring T. gondii during pregnancy: implications for clinical practices and cross sectional incidence studies, Epidemiol Infect, 132, 541, 10.1017/S0950268803001948 Gilbert RE, Petersen E, Thalib L, Gras L, Paul M, Wallon M, et al. The European Multicentre Study on Congenital Toxoplasmosis (EMSCOT). Accuracy of IgM and IgA tests for congenital toxoplasmosis in early infancy: results from the European multicentre study. J Med Screen, in press. Wallon, 2001, Serological rebound in congenital toxoplasmosis: long-term follow-up of 133 children, Eur J Pediatr, 160, 534, 10.1007/s004310100805 Buffolano, 2005, Use of recombinant antigens for early postnatal diagnosis of congenital toxoplasmosis, J Clin Microbiol, 43, 5916, 10.1128/JCM.43.12.5916-5924.2005 Robert-Gangneux, 1999, Performance of a Western blot assay to compare mother and newborn anti-Toxoplasma antibodies for the early neonatal diagnosis of congenital toxoplasmosis, Eur J Clin Microbiol Infect Dis, 18, 648, 10.1007/s100960050366 Gross, 2000, Comparative immunoglobulin G antibody profiles between mother and child (CGMC test) for early diagnosis of congenital toxoplasmosis, J Clin Microbiol, 38, 3619, 10.1128/JCM.38.10.3619-3622.2000 Remington, 2004, Recent developments for diagnosis of toxoplasmosis, J Clin Microbiol, 42, 941, 10.1128/JCM.42.3.941-945.2004 Pinon, 2001, Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies, J Clin Microbiol, 39, 2267, 10.1128/JCM.39.6.2267-2271.2001 Rilling, 2003, Evaluation of a commercial IgG/IgM Western blot assay for early postnatal diagnosis of congenital toxoplasmosis, Eur J Clin Microbiol Infect Dis, 22, 174, 10.1007/s10096-003-0906-6 Tissot-Dupont, 2003, Usefulness of Western blot in serological follow-up of newborns suspected of congenital toxoplasmosis, Eur J Clin Microbiol Infect Dis, 22, 122, 10.1007/s10096-003-0887-5 Nielsen, 2005, Diagnosis of congenital toxoplasmosis by two-dimensional immunoblot differentiation of mother and child IgG-profiles, J Clin Microbiol, 43, 711, 10.1128/JCM.43.2.711-715.2005 Dunn, 1999, Mother to child transmission of toxoplasmosis: risk estimates for clinical counselling, Lancet, 353, 1829, 10.1016/S0140-6736(98)08220-8 Bénard A, Salmi R. Survey on the programs implemented in Europe for the epidemiological surveillance of congenital toxoplasmosis. Available at: http://eurotoxo.isped.u-bordeaux2.fr/WWW_PUBLIC/DOC/EUROTOXO_Panel_1_Survey_on_surveillance_systems_27-04-2006.pdf [Accessed 20 August 2006]. Ades, 1991, Evaluating the sensitivity and predictive value of tests of recent infection: toxoplasmosis in pregnancy, Epidemiol Infect, 107, 527, 10.1017/S0950268800049220 Thiébaut R, Bricout H, Costanzo S di, Mouillet E. Systematic review of published studies evaluating postnatal treatment effect. Available at: http://eurotoxo.isped.u-bordeaux2.fr/WWW_PUBLIC/DOC/Postnatal_effect_v25082005.pdf [Accessed 15 August 2006]. Aspock, 1992, Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria, Scand J Infect Dis, 32 Aspock, 2003, Prevention of congenital toxoplasmosis in Austria, Arch Pediatr, 10, 16 Binquet, 2004, Toxoplasmosis seroconversion in pregnant women. The differing attitudes in France, Presse Med, 33, 775, 10.1016/S0755-4982(04)98742-8 Logar, 2002, Prevention of congenital toxoplasmosis in Slovenia by serological screening of pregnant women, Scand J Infect Dis, 34, 201, 10.1080/00365540110080386 Remington, 2001, Toxoplasmosis, 205 Wallon, 1999, Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy, Br Med J, 318, 1511, 10.1136/bmj.318.7197.1511 Peyron, 2000, Treatments for toxoplasmosis in pregnancy, Cochrane Database Syst Rev, 2, CD001684 Gilbert, 2003, Gras L for the European Multicentre Study on Congenital Toxoplasmosis. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii, Br J Obsest Gyneacol, 110, 112, 10.1016/S1470-0328(02)02325-X 2007, Individual patient data meta-analysis of prenatal treatment effect for congenital toxoplasmosis, Lancet, 369, 115, 10.1016/S0140-6736(07)60072-5 Freeman, 2005, Association between congenital toxoplasmosis and parent-reported developmental outcomes, concerns, and impairments, in 3 year old children, BMC Pediatr, 5, 1 Khoshnood B, Vigan D de, Goffinet F, Leroy V., Prenatal screening and diagnosis of congenital toxoplasmosis: a review of safety issues and psychological consequences for women who undergo screening. Available at: http://eurotoxo.isped.u-bordeaux2.fr/WWW_PUBLIC/DOC/EUROTOXO_R4_P3_Safety_prenatal_screening_Sept2005.pdf [Accessed 15 August 2006]. Roizen, 2006, Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies, Pediatrics, 118, e379, 10.1542/peds.2005-1530 Gras, 2005, Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres, Acta Paediatr, 94, 1721, 10.1080/08035250500251999 Guerina, 1994, Neonatal serologic screening and early treatment for congenital T. gondii infection, N Engl J Med, 330, 1858, 10.1056/NEJM199406303302604 Schmidt, 2006, The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999–2002, Arch Dis Child, 91, 661, 10.1136/adc.2004.066514 Decoster, 1992, Anti-P30 IgA antibodies as prenatal markers of congenital toxoplasma infection, Clin Exp Immunol, 87, 310, 10.1111/j.1365-2249.1992.tb02993.x Paul, 2001, Prevalence of congenital Toxoplasma gondii infection among newborns from the Poznan region of Poland: validation of a new combined enzyme immunoassay for Toxoplasma gondii-specific immunoglobulin A and immunoglobulin M antibodies, J Clin Microbiol, 39, 1912, 10.1128/JCM.39.5.1912-1916.2001 Leroy V, Harambat J, Perez P, Rudin C, Gilbert R, Petersen E., Performance of test involved in screening and diagnosis of acute maternal toxoplasmosis during pregnancy and congenital infection. Available at: http://eurotoxo.isped.u-bordeaux2.fr/WWW_PUBLIC/DOC/EUROTOXO_R5_P3_Performances_diag_tools_April2006.pdf [Accessed 14 August 2006]. Mets, 1996, Eye manifestations of congenital toxoplasmosis, Am J Ophthalmol, 122, 309, 10.1016/S0002-9394(14)72057-4 McAuley, 1994, Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial, Clin Infect Dis, 18, 38, 10.1093/clinids/18.1.38 Wallon, 2004, Long-term ocular prognosis in 327 children with congenital toxoplasmosis, Pediatrics, 113, 1567, 10.1542/peds.113.6.1567 Schmidt, 2006, Treatment of infants with congenital toxoplasmosis: tolerability and plasma concentrations of sulfadiazine and pyrimethamine, Eur J Pediatr, 165, 19, 10.1007/s00431-005-1665-4 Bénard A, Salmi R., Systematic review of published data on the burden of congenital toxoplasmosis in Europe. Available at: http://eurotoxo.isped.u-bordeaux2.fr/WWW_PUBLIC/DOC/EUROTOXO_Panel_1_Sytematic_review_on_the_burden_of_CT_30-01-2006.pdf [Accessed 15 August 2006]. Janitschke, 2003, Official recommendations and strategy for prevention of congenital toxoplasmosis in Germany, Arch Pediatr, 10, 15 Joynson, 2003, Congenital toxoplasma infection in the UK, Arch Pediatr, 10, 27 Lappalainen, 2003, Current situation regarding toxoplasmosis in Finland, Arch Pediatr, 10, 19 Stray-Pedersen, 2003, Prevention of congenital toxoplasmosis in Norway, Arch Pediatr, 10, 23 Villena, 1998, Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997, Scand J Infect Dis, 30, 295, 10.1080/00365549850160963 Signorell, 1996, Cord blood screening for congenital toxoplasmosis in northwestern Switzerland, 1982–1999, Pediatr Infect Dis J, 25, 123, 10.1097/01.inf.0000195542.43369.96 Petersen, 2003, Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options?, Expert Rev Anti Infect Ther, 1, 175, 10.1586/14787210.1.1.175 Couvreur, 1980, La toxoplasmose congenitale traitee. Resultats cliniques et biologiques, Ann Pediatr (Paris), 27, 647 Gilbert, 2001, Ecological comparison of the risks of mother-to-child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment period, Epidemiol Infect, 127, 113, 10.1017/S095026880100560X Gilbert, 2002, Antibiotics for treating and preventing toxoplasma retinochoroiditis, The Cochrane Library, 3 McLeod, 2006, Outcome of treatment for congenital toxoplasmosis, 1981–2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study, Clin Infect Dis, 42, 1383, 10.1086/501360 Huskinson-Mark, 1991, Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii, J Infect Dis, 164, 170, 10.1093/infdis/164.1.170 Derouin F. Systematic search and analysis of preclinical published data on in vitro and in vivo activities of antitoxoplasma drugs. Available at: http://eurotoxo.isped.u-bordeaux2.fr/WWW_PUBLIC/DOC/Pharmacodynamics_v26082005.pdf[Accessed 15 August 2006]. Derouin, 1992, Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis, Antimicrob Agents Chemother, 36, 997, 10.1128/AAC.36.5.997 Araujo, 1998, Use of ketolides in combination with other drugs to treat experimental toxoplasmosis, J Antimicrob Chemother, 42, 665, 10.1093/jac/42.5.665 Djurkovic-Djakovic, 2002, Efficacy of atovaquone combined with clindamycin against murine infection with a cystogenic (Me49) strain of Toxoplasma gondii, J Antimicrob Chemother, 50, 981, 10.1093/jac/dkf251 Alves, 2005, Efficacy of atovaquone and sulfadiazine in the treatment of mice infected with Toxoplasma gondii strains isolated in Brazil, Parasite, 12, 171, 10.1051/parasite/2005122171 Stramba-Badiale, 1997, QT interval prolongation and risk of life-threatening arrhythmias during toxoplasmosis prophylaxis with spiramycin in neonates, Am Heart J, 133, 108, 10.1016/S0002-8703(97)70255-2 Caramello, 1995, Relapse of Toxoplasma encephalitis and susceptibility to pyrimethamine: lack of evidence of treatment-induced resistance, Antimicrob Agents Chemother, 39, 2371, 10.1128/AAC.39.10.2371 Pfefferkorn, 1992, Toxoplasma gondii: characterization of a mutant resistant to sulfonamides, Exp Parasitol, 74, 261, 10.1016/0014-4894(92)90149-5 Aspinall, 2002, The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis, J Infect Dis, 185, 1637, 10.1086/340577 Peyron, 2004, Fitness of Toxoplasma gondii is not related to DHFR single-nucleotide polymorphism during congenital toxoplasmosis, Int J Parasitol, 34, 1169, 10.1016/j.ijpara.2004.05.009 Petersen E, Liesenfeld O. Clinical disease and diagnostics. In: Weiss LM, Kim K, editors. Toxoplasma gondii: the model apicomplexan—perspectives and methods. Amsterdam: Elsevier Academic Press; Chapter 4; 2007.